{"ticker": {"uuid": "d690d1f2-c6ad-43ae-bc45-030768e8fa28", "symbol": "PTN", "name": "Palatin Technologies, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Palatin stock trades quietly as revenue stabilizes after FY 2025 loss", "summary": "Palatin Technologies (PTN) stock is trading quietly after reporting stabilized revenue and a narrowed net loss for fiscal year 2025. The biotech company saw its total revenue increase to $16.3 million from $10.4 million in FY 2024, primarily driven by sales of its lead product Vy", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/palatin-stock-trades-quietly-as-revenue-stabilizes-after-fy-2025-loss/69823414", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T14:35:00", "published_display": "21 Jul 2026 14:35", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies (PTN) CEO has 294 shares withheld for taxes", "summary": "Carl Spana, President and CEO of Palatin Technologies (PTN), reported three F-code transactions on July 15, 2026, involving the withholding of 294 common shares by the issuer. These shares, valued at $14.34, $11.72, and $11.77 per share, were used to satisfy employee withholding ", "url": "https://www.stocktitan.net/sec-filings/PTN/form-4-palatin-technologies-inc-insider-trading-activity-b0be32359a93.html", "source_name": "Stock Titan", "published_at": "2026-07-17T20:39:53", "published_display": "17 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies (PTN) CFO has 195 shares withheld for taxes", "summary": "Palatin Technologies' Executive VP and CFO/COO, Stephen T. Wills, had 195 shares of common stock withheld for tax-withholding dispositions on July 15, 2026. These shares were withheld to cover employee withholding taxes on recently vested equity grants, with per-share values rang", "url": "https://www.stocktitan.net/sec-filings/PTN/form-4-palatin-technologies-inc-insider-trading-activity-563580f482ee.html", "source_name": "Stock Titan", "published_at": "2026-07-17T20:39:53", "published_display": "17 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Palatin Technologies explores drug pipeline as investors track Nasdaq listing", "summary": "Palatin Technologies, a biotech company specializing in melanocortin receptor therapies, is advancing its drug pipeline, with a focus on areas like sexual dysfunction, inflammatory diseases, and metabolic disorders. Its shares trade on Nasdaq, and investors are keenly watching fu", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/palatin-technologies-explores-drug-pipeline-as-investors-track-nasdaq/69725026", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T17:50:00", "published_display": "08 Jul 2026 17:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to cash flow ratio of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article provides the price to cash flow ratio for Palatin Technologies, Inc. (NASDAQ: PTN). It lists the period, value, and change metrics for this financial indicator but does not include the actual numerical values. The content is presented as part of a financial data over", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/price-cash-flow/", "source_name": "TradingView", "published_at": "2026-07-07T22:41:25", "published_display": "07 Jul 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tangible book value per share of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "The article focuses on the tangible book value per share of Palatin Technologies, Inc. (NASDAQ: PTN), providing a financial overview of the company through TradingView. It highlights that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr. The ", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/book-tangible-per-share/", "source_name": "TradingView", "published_at": "2026-07-06T04:11:34", "published_display": "06 Jul 2026 04:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A41E9H Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Palatin Technologies, Inc. (A41E9H) stock, including analyst price targets and future earnings estimates. It details the company's past earnings and revenue performance, upcoming earnings report date, and confirms that A41E9H does not pay divi", "url": "https://www.tradingview.com/symbols/LSX-A41E9H/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-07-03T06:09:28", "published_display": "03 Jul 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc. Actuals & Estimates (LSX:A41E9H)", "summary": "This article provides financial actuals and estimates for Palatin Technologies, Inc. (LSX:A41E9H), including income statement, balance sheet, and cash flow data. It also covers analyst forecasts, earnings reports, and key financial metrics like revenue, net income, and dividend p", "url": "https://www.tradingview.com/symbols/LSX-A41E9H/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-07-02T19:39:55", "published_display": "02 Jul 2026 19:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc.(NasdaqCM:PTN) added to Russell Microcap Growth Benchmark Index", "summary": "Palatin Technologies, Inc. (NasdaqCM:PTN) has been added to the Russell Microcap Growth Benchmark Index, as announced on June 28, 2026. This inclusion highlights the biopharmaceutical company's growth and increased visibility within the market, following recent additions to other", "url": "https://www.marketscreener.com/news/palatin-technologies-inc-nasdaqcm-ptn-added-to-russell-microcap-growth-benchmark-index-ce7f5fddd98cf127", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T17:40:50", "published_display": "29 Jun 2026 17:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article provides the enterprise value to EBIT forward for Palatin Technologies, Inc. (NASDAQ: PTN). The content is a snippet from a financial data platform, likely TradingView, focusing on the company's financial overview. It does not provide any detailed analysis or specifi", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T08:40:56", "published_display": "28 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc. Actuals & Estimates (LS:A41E9H)", "summary": "This article provides an overview of Palatin Technologies, Inc. (A41E9H) financial actuals and estimates, including income statement, balance sheet, and cash flow data. It details recent earnings, revenue, and net income figures, and shares analyst forecasts for future stock pric", "url": "https://www.tradingview.com/symbols/LS-A41E9H/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T20:39:49", "published_display": "27 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article briefly highlights the \"Enterprise value to revenue forward\" metric for Palatin Technologies, Inc. (NASDAQ: PTN). The content appears to be a financial data snippet from TradingView, indicating a specific period and value for this metric, without providing further an", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T20:39:35", "published_display": "27 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc. Actuals & Estimates (NASDAQ:PTN)", "summary": "This article provides an overview of Palatin Technologies, Inc. (NASDAQ: PTN) stock, including financial data, analyst estimates, and price performance. It covers current stock price movements, historical highs and lows, market capitalization, and upcoming earnings report dates. ", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T15:08:53", "published_display": "26 Jun 2026 15:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article provides the \"Price to book forward\" value for Palatin Technologies, Inc. (NASDAQ:PTN). It indicates that the market was closed at the time of publication and there were no trades. The core content focuses solely on this specific financial metric for PTN.", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T11:39:31", "published_display": "26 Jun 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Is Pursuing the Next Generation of MC4R. Rhythm Just Reinforced Why That Matters", "summary": "Rhythm Pharmaceuticals' recent positive Phase 2 data for setmelanotide in Prader-Willi syndrome strengthens the therapeutic thesis for activating the melanocortin-4 receptor (MC4R). This validation benefits smaller competitor Palatin Technologies, which is developing next-generat", "url": "https://www.tradingview.com/news/financewire:ede27d494094b:0-palatin-technologies-is-pursuing-the-next-generation-of-mc4r-rhythm-just-reinforced-why-that-matters/", "source_name": "TradingView", "published_at": "2026-06-19T20:10:37", "published_display": "19 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Palatin Technologies Inc (PTN), highlighting its current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock is currently trading between a resistance level of 14.05 and a sup", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/technical", "source_name": "TradingKey", "published_at": "2026-06-19T00:39:58", "published_display": "19 Jun 2026 00:39", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Palatin Technologies Inc (PTN) has an earnings forecast score of 8.00, placing it highly within the Biotechnology & Medical Research industry. Analysts provide a strong buy rating with an average price target of $51.50, indicating significant upside potential. The company's expec", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/earnings", "source_name": "TradingKey", "published_at": "2026-06-19T00:39:37", "published_display": "19 Jun 2026 00:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Institutional Confidence", "summary": "Palatin Technologies Inc (PTN) has an institutional shareholding score of 3.00, placing it 193rd out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 5.52%, marking an 89.11% decrease quarter-over-quarter. Steven Cohen i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T00:39:37", "published_display": "19 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a company valuation for Palatin Technologies Inc (PTN), noting that no specific valuation score is currently available. It highlights the company's P/E ratio of 107.30 and compares it to recent highs and lows, as well as the industry average in Biotechnology", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T21:39:37", "published_display": "18 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Palatin Technologies Inc (PTN), listing its major institutional and individual shareholders. It provides a breakdown of shareholder types, including investment advisors, hedge funds, and venture capitalists, along with institution", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T08:18:39", "published_display": "18 Jun 2026 08:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Palatin Technologies Inc (PTN) regarding its dividend history and stock splits. It states that PTN has not distributed any dividends over the past five years and details multiple 25-to-1 merger-related stock splits on August 22, 2022. The page", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T07:39:08", "published_display": "18 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey concerns Palatin Technologies Inc (PTN) and aims to provide a breakdown of its revenue by business segments and regions. However, the article states that the relevant data for these breakdowns have not been disclosed by the company yet. It primarily s", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T05:18:39", "published_display": "18 Jun 2026 05:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc. Cash Flow \u2013 NASDAQ:PTN", "summary": "Palatin Technologies, Inc. (NASDAQ:PTN) reported a free cash flow of -4.46 million USD for Q3 2026. For the full year 2025, the company's free cash flow and operating cash flow were both -21.31 million USD. This data provides insight into the company's financial performance relat", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-cash-flow/", "source_name": "TradingView", "published_at": "2026-06-11T01:11:11", "published_display": "11 Jun 2026 01:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Book value per share of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "The article focuses on the book value per share of Palatin Technologies, Inc. (NASDAQ: PTN). It appears to be a financial data presentation that likely shows the period value and changes related to the company's book value per share. The content is primarily a structural page fro", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/book-value-per-share/", "source_name": "TradingView", "published_at": "2026-06-10T20:40:26", "published_display": "10 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total operating expenses of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "The article provides financial information for Palatin Technologies, Inc. (NASDAQ: PTN), specifically focusing on its total operating expenses. It is presented on TradingView, a platform offering market data and financial tools.", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-income-statement/total-oper-expense/", "source_name": "TradingView", "published_at": "2026-06-10T18:09:51", "published_display": "10 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Operating expenses (excl. COGS) of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article displays the operating expenses (excluding Cost of Goods Sold) for Palatin Technologies, Inc. (NASDAQ: PTN). It appears to be a financial data snippet from TradingView, providing an overview of the company's financial metrics. The article itself does not provide deta", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-income-statement/operating-expenses/", "source_name": "TradingView", "published_at": "2026-06-10T05:09:20", "published_display": "10 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cash from investing activities of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article provides access to the \"Cash from investing activities\" financial data for Palatin Technologies, Inc. (NASDAQ: PTN) on TradingView. It indicates that the market for PTN was closed at the time of viewing. The content also lists various features and financial tools ava", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-cash-flow/cash-f-investing-activities/", "source_name": "TradingView", "published_at": "2026-06-09T15:39:59", "published_display": "09 Jun 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc. Statistics \u2013 NASDAQ:PTN", "summary": "This page provides financial statistics for Palatin Technologies, Inc. (NASDAQ: PTN), including key financial stats, valuation ratios, profitability ratios, liquidity ratios, solvency ratios, and per-share metrics. Users can view annual and quarterly data from 2006 to 2025, altho", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/", "source_name": "TradingView", "published_at": "2026-06-08T22:39:59", "published_display": "08 Jun 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Revenue per share of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "The article focuses on the revenue per share information for Palatin Technologies, Inc. (NASDAQ: PTN), as presented on TradingView. It indicates that the market was closed at the time of viewing. The content primarily highlights the financial data and corporate information availa", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/revenue-per-share/", "source_name": "TradingView", "published_at": "2026-06-08T22:39:35", "published_display": "08 Jun 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quick ratio of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article is a financial data page from TradingView for Palatin Technologies, Inc. (NASDAQ: PTN), focusing on its quick ratio. It provides a placeholder for the quick ratio value, change, and change percentage, and lists various services and disclaimers related to the market d", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/quick-ratio/", "source_name": "TradingView", "published_at": "2026-06-08T12:10:36", "published_display": "08 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies (PTN) Hovers Near Support as Biotech Sentiment Remains Cautious - Triple MA Cross", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPdWlWb28zbmtydDlCMV8yWE01VjNPa0dxTG5VZ2lNX0xSR0U3UXJfbE43bmJCcFl1YW1xZ3Nmd2FoYnZXdV81a1BOZE93VFJWWnlfYW5xZ1BMVWY3a0x2d3ZsT2FkbDlJb3diMUthandLbDl6MjNFbEc0SDI0MFF4b2NGbUNOcmR5T0I4YktfVllEZVNIcTV3TlpSVHUtSWJOeFJsSlQxTUFZQy1RSmM4NTE3eVVHUzQwT093MQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PTN Stock Price and Chart \u2014 NASDAQ:PTN", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE1uYkNzQVBUZDZOdjNnbXpQUW51bUtaLTg5cFExT2czS2xKZkxkVm5EcWkzR1BFOGlrbFlBb3NjVFJWbU54MTdWX2hWT3dsZ01nRGVXSlN3aHpvNXc?oc=5", "source_name": "TradingView", "published_at": "2026-05-29T09:18:43+00:00", "published_display": "29 May 2026 09:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies to Transfer Listing to Nasdaq", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/palatin-technologies-transfer-listing-nasdaq-213555362.html", "source_name": "MT Newswires", "published_at": "2026-05-18T21:35:55+00:00", "published_display": "18 May 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin to Begin Trading on Nasdaq Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOcV9xazhvWlI5ekxrNFBrSVZrN3lPOWRSLUlLY3ZVZjNFTU5kR3pOZ0tiQVp2YlZ2RUFKVml5Q2hMYzAzRUNHdjV0QkU5Xy1LWmJNWEExZDVQSklhME1zeDVmbDF3enQ0ZGxCV0FhX0VPWXRFV1BBUHAzM1ZGV29IQXBQajZJa21KWDZwZURmekk3QTJob0ljNTAwRDE4eEVZUC1KaW1tSy0?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Announced Transfer or Voluntary Withdrawal of Listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxONjlnN0tlM1NONVdCS0N1V00wVW5vbnpIWlY0YWp5Tk1NR3ZXVWtuMEluSUxMODkxVF9OelpUNHktTFhIX3l6T29TZ1dRMjZvbnZLZ1o1c0N2Q2E3ZklsTTVuRlh0VkkxYUZyeUNVdGZUc3daS0VBM1lIcEJfMVU2MlFiY2ZUSmJpTG55T2NVa080WHRjRkdyOFNFcUhnUmlva1NLcWozVVJsMEJJUXNCQUplTEJ6T0lGYXBSTlk4RTQ4OVRGbVRpZElLYVJKQm91YWc?oc=5", "source_name": "TradingView", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Palatin Technologies stock (US69608A1088): Q3 revenue jumps to $3.9M, loss narrows", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNaG1YbXQ2d1pyVFdCallxT2RlVzNDZ3E4bTJJZVl2T19EN3hwLUJmWFJPc0F3VTFXTVoyTlJkVDI1ZUlBOUhZZ2Yzb2hrN19KUGhMd2ZqdXgweWZfQ19yRzBvRi1FdTlLOFBhUEx4ZklHLUZGS2lLV0VHSVI5Znd0S1ItTVEtY003TkZQemtzTmhJa1NVX2ZlRnNkZnBNdW9IX2tVSnhFYmdVVzVYazJiWjJmX2JsUVJnZnRKNWE1TkxhQXFRWEww?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Palatin Technologies Inc (PTN) Q3 2026 Earnings Call Highlights: Strategic Advances Amidst ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/palatin-technologies-inc-ptn-q3-230342249.html", "source_name": "GuruFocus.com", "published_at": "2026-05-13T23:03:42+00:00", "published_display": "13 May 2026 23:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Transcript: Palatin Techs Q3 2026 Earnings Conference Call", "summary": "", "url": "https://finance.yahoo.com/news/transcript-palatin-techs-q3-2026-153125171.html", "source_name": "Benzinga", "published_at": "2026-05-13T15:31:25+00:00", "published_display": "13 May 2026 15:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQSXBoS2dWSG1FalFVeHY2QWViamRvSmhlTVJFVDhDVWxrMHpUQ2o1OUN0LUVXb0RrR2ZMTUNhM2J5bTRDVWlSVENuMnlRbTVQNHhjOGZmN0RYUFZSY3EyMmtuRTVkcVFXY1FmbUd0OWhwcDJCTmZmV2FCUWlIdnd2TFFiV2lfTXVwTENCRVk4bEM1ZzdldXgzMjY4cnlXNWtySHJzeE1KYkhYam5wcWs1T1N5M0JBLXEwYXVXXzdsVV9Lcmg2UnJIUkl0R3AtNEJUUUt1RDg2Y01vNHJW?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies (PTNT) Stock Price, News & Analysis $PTNT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE5LNEFnbkNBVVZDOWsxVVpFaTBjOGZFMk9Jcjd3TV8tVDZfajYxMWh2Y1AwbFBrUWU0SE14ZUdPNzdKZmtkdTdTYU1Fa3dPQTJmd3dkSklWRkhXWnc?oc=5", "source_name": "MarketBeat", "published_at": "2026-03-16T19:04:03+00:00", "published_display": "16 Mar 2026 19:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNbk9ldkFQQlNMbXlUWGJNLVMwMDFLZ094Q2dydlpMb21pQmlnNXFtRW84bDhVeVJQVUdUbGszV3h3MkYwVXFLRi1icmFWTEtwaERVb1k1a19XbWFlR2RyQXRuNHpzSEZmVy1hcFZPQ1JhcllrVzBjVlgyV3lOalVHUUt2bzFQa1hvMGJTMjRsd081SzlSYkMzMTFLZDg5bFIwSU5CdmgzNHdVYmpmVEdURFotWE9taW5QWmI0bUtCRVRJejI2b0V1RGtJVUUxNzhqQjdHMy1La0ZWSXZYVXh5LTBHcHhmdw?oc=5", "source_name": "PR Newswire", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Palatin stock trades quietly as revenue stabilizes after FY 2025 loss", "summary": "Palatin Technologies (PTN) stock is trading quietly after reporting stabilized revenue and a narrowed net loss for fiscal year 2025. The biotech company saw its total revenue increase to $16.3 million from $10.4 million in FY 2024, primarily driven by sales of its lead product Vy", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/palatin-stock-trades-quietly-as-revenue-stabilizes-after-fy-2025-loss/69823414", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-21T14:35:00", "published_display": "21 Jul 2026 14:35", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies (PTN) CEO has 294 shares withheld for taxes", "summary": "Carl Spana, President and CEO of Palatin Technologies (PTN), reported three F-code transactions on July 15, 2026, involving the withholding of 294 common shares by the issuer. These shares, valued at $14.34, $11.72, and $11.77 per share, were used to satisfy employee withholding ", "url": "https://www.stocktitan.net/sec-filings/PTN/form-4-palatin-technologies-inc-insider-trading-activity-b0be32359a93.html", "source_name": "Stock Titan", "published_at": "2026-07-17T20:39:53", "published_display": "17 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies (PTN) CFO has 195 shares withheld for taxes", "summary": "Palatin Technologies' Executive VP and CFO/COO, Stephen T. Wills, had 195 shares of common stock withheld for tax-withholding dispositions on July 15, 2026. These shares were withheld to cover employee withholding taxes on recently vested equity grants, with per-share values rang", "url": "https://www.stocktitan.net/sec-filings/PTN/form-4-palatin-technologies-inc-insider-trading-activity-563580f482ee.html", "source_name": "Stock Titan", "published_at": "2026-07-17T20:39:53", "published_display": "17 Jul 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies explores drug pipeline as investors track Nasdaq listing", "summary": "Palatin Technologies, a biotech company specializing in melanocortin receptor therapies, is advancing its drug pipeline, with a focus on areas like sexual dysfunction, inflammatory diseases, and metabolic disorders. Its shares trade on Nasdaq, and investors are keenly watching fu", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/palatin-technologies-explores-drug-pipeline-as-investors-track-nasdaq/69725026", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T17:50:00", "published_display": "08 Jul 2026 17:50", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to cash flow ratio of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article provides the price to cash flow ratio for Palatin Technologies, Inc. (NASDAQ: PTN). It lists the period, value, and change metrics for this financial indicator but does not include the actual numerical values. The content is presented as part of a financial data over", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/price-cash-flow/", "source_name": "TradingView", "published_at": "2026-07-07T22:41:25", "published_display": "07 Jul 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tangible book value per share of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "The article focuses on the tangible book value per share of Palatin Technologies, Inc. (NASDAQ: PTN), providing a financial overview of the company through TradingView. It highlights that market data is provided by ICE Data Services and FactSet, with SEC filings from Quartr. The ", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/book-tangible-per-share/", "source_name": "TradingView", "published_at": "2026-07-06T04:11:34", "published_display": "06 Jul 2026 04:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A41E9H Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Palatin Technologies, Inc. (A41E9H) stock, including analyst price targets and future earnings estimates. It details the company's past earnings and revenue performance, upcoming earnings report date, and confirms that A41E9H does not pay divi", "url": "https://www.tradingview.com/symbols/LSX-A41E9H/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-07-03T06:09:28", "published_display": "03 Jul 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc. Actuals & Estimates (LSX:A41E9H)", "summary": "This article provides financial actuals and estimates for Palatin Technologies, Inc. (LSX:A41E9H), including income statement, balance sheet, and cash flow data. It also covers analyst forecasts, earnings reports, and key financial metrics like revenue, net income, and dividend p", "url": "https://www.tradingview.com/symbols/LSX-A41E9H/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-07-02T19:39:55", "published_display": "02 Jul 2026 19:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc.(NasdaqCM:PTN) added to Russell Microcap Growth Benchmark Index", "summary": "Palatin Technologies, Inc. (NasdaqCM:PTN) has been added to the Russell Microcap Growth Benchmark Index, as announced on June 28, 2026. This inclusion highlights the biopharmaceutical company's growth and increased visibility within the market, following recent additions to other", "url": "https://www.marketscreener.com/news/palatin-technologies-inc-nasdaqcm-ptn-added-to-russell-microcap-growth-benchmark-index-ce7f5fddd98cf127", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T17:40:50", "published_display": "29 Jun 2026 17:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article provides the enterprise value to EBIT forward for Palatin Technologies, Inc. (NASDAQ: PTN). The content is a snippet from a financial data platform, likely TradingView, focusing on the company's financial overview. It does not provide any detailed analysis or specifi", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/enterprise-value-ebit-fwd/", "source_name": "TradingView", "published_at": "2026-06-28T08:40:56", "published_display": "28 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc. Actuals & Estimates (LS:A41E9H)", "summary": "This article provides an overview of Palatin Technologies, Inc. (A41E9H) financial actuals and estimates, including income statement, balance sheet, and cash flow data. It details recent earnings, revenue, and net income figures, and shares analyst forecasts for future stock pric", "url": "https://www.tradingview.com/symbols/LS-A41E9H/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-27T20:39:49", "published_display": "27 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to revenue forward of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article briefly highlights the \"Enterprise value to revenue forward\" metric for Palatin Technologies, Inc. (NASDAQ: PTN). The content appears to be a financial data snippet from TradingView, indicating a specific period and value for this metric, without providing further an", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/enterprise-value-sales-fwd/", "source_name": "TradingView", "published_at": "2026-06-27T20:39:35", "published_display": "27 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc. Actuals & Estimates (NASDAQ:PTN)", "summary": "This article provides an overview of Palatin Technologies, Inc. (NASDAQ: PTN) stock, including financial data, analyst estimates, and price performance. It covers current stock price movements, historical highs and lows, market capitalization, and upcoming earnings report dates. ", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T15:08:53", "published_display": "26 Jun 2026 15:08", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article provides the \"Price to book forward\" value for Palatin Technologies, Inc. (NASDAQ:PTN). It indicates that the market was closed at the time of publication and there were no trades. The core content focuses solely on this specific financial metric for PTN.", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T11:39:31", "published_display": "26 Jun 2026 11:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Is Pursuing the Next Generation of MC4R. Rhythm Just Reinforced Why That Matters", "summary": "Rhythm Pharmaceuticals' recent positive Phase 2 data for setmelanotide in Prader-Willi syndrome strengthens the therapeutic thesis for activating the melanocortin-4 receptor (MC4R). This validation benefits smaller competitor Palatin Technologies, which is developing next-generat", "url": "https://www.tradingview.com/news/financewire:ede27d494094b:0-palatin-technologies-is-pursuing-the-next-generation-of-mc4r-rhythm-just-reinforced-why-that-matters/", "source_name": "TradingView", "published_at": "2026-06-19T20:10:37", "published_display": "19 Jun 2026 20:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Palatin Technologies Inc (PTN), highlighting its current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock is currently trading between a resistance level of 14.05 and a sup", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/technical", "source_name": "TradingKey", "published_at": "2026-06-19T00:39:58", "published_display": "19 Jun 2026 00:39", "sentiment": "negative", "sentiment_pct": 18, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Palatin Technologies Inc (PTN) has an earnings forecast score of 8.00, placing it highly within the Biotechnology & Medical Research industry. Analysts provide a strong buy rating with an average price target of $51.50, indicating significant upside potential. The company's expec", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/earnings", "source_name": "TradingKey", "published_at": "2026-06-19T00:39:37", "published_display": "19 Jun 2026 00:39", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Institutional Confidence", "summary": "Palatin Technologies Inc (PTN) has an institutional shareholding score of 3.00, placing it 193rd out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 5.52%, marking an 89.11% decrease quarter-over-quarter. Steven Cohen i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/sentiment", "source_name": "TradingKey", "published_at": "2026-06-19T00:39:37", "published_display": "19 Jun 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a company valuation for Palatin Technologies Inc (PTN), noting that no specific valuation score is currently available. It highlights the company's P/E ratio of 107.30 and compares it to recent highs and lows, as well as the industry average in Biotechnology", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-18T21:39:37", "published_display": "18 Jun 2026 21:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Palatin Technologies Inc (PTN), listing its major institutional and individual shareholders. It provides a breakdown of shareholder types, including investment advisors, hedge funds, and venture capitalists, along with institution", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/ownership", "source_name": "TradingKey", "published_at": "2026-06-18T08:18:39", "published_display": "18 Jun 2026 08:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Palatin Technologies Inc (PTN) regarding its dividend history and stock splits. It states that PTN has not distributed any dividends over the past five years and details multiple 25-to-1 merger-related stock splits on August 22, 2022. The page", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T07:39:08", "published_display": "18 Jun 2026 07:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article from TradingKey concerns Palatin Technologies Inc (PTN) and aims to provide a breakdown of its revenue by business segments and regions. However, the article states that the relevant data for these breakdowns have not been disclosed by the company yet. It primarily s", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-ptn/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T05:18:39", "published_display": "18 Jun 2026 05:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Rises 19% in 3 Months: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxObTdhSlJXM3BhWXRZM1NuWVBvNFZKS09CUkMyLV93TEdVQUdycktzUG5tRnFwUFlabkluMDFsMUpYYzFiQUxPWVdwczhNeVVjN0Rvc2k3VUZuS3NlTmEycHVpMGV1eDhnaEZkQ1JCaHVkcVZnMGd6Q2xzYnVpZV9tVVRLcjZnaWd0NlRhSnRENWIxSzhBQkd5WnRxVXN4dkk?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc. Cash Flow \u2013 NASDAQ:PTN", "summary": "Palatin Technologies, Inc. (NASDAQ:PTN) reported a free cash flow of -4.46 million USD for Q3 2026. For the full year 2025, the company's free cash flow and operating cash flow were both -21.31 million USD. This data provides insight into the company's financial performance relat", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-cash-flow/", "source_name": "TradingView", "published_at": "2026-06-11T01:11:11", "published_display": "11 Jun 2026 01:11", "sentiment": "negative", "sentiment_pct": 39, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Book value per share of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "The article focuses on the book value per share of Palatin Technologies, Inc. (NASDAQ: PTN). It appears to be a financial data presentation that likely shows the period value and changes related to the company's book value per share. The content is primarily a structural page fro", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/book-value-per-share/", "source_name": "TradingView", "published_at": "2026-06-10T20:40:26", "published_display": "10 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Total operating expenses of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "The article provides financial information for Palatin Technologies, Inc. (NASDAQ: PTN), specifically focusing on its total operating expenses. It is presented on TradingView, a platform offering market data and financial tools.", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-income-statement/total-oper-expense/", "source_name": "TradingView", "published_at": "2026-06-10T18:09:51", "published_display": "10 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Operating expenses (excl. COGS) of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article displays the operating expenses (excluding Cost of Goods Sold) for Palatin Technologies, Inc. (NASDAQ: PTN). It appears to be a financial data snippet from TradingView, providing an overview of the company's financial metrics. The article itself does not provide deta", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-income-statement/operating-expenses/", "source_name": "TradingView", "published_at": "2026-06-10T05:09:20", "published_display": "10 Jun 2026 05:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cash from investing activities of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article provides access to the \"Cash from investing activities\" financial data for Palatin Technologies, Inc. (NASDAQ: PTN) on TradingView. It indicates that the market for PTN was closed at the time of viewing. The content also lists various features and financial tools ava", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-cash-flow/cash-f-investing-activities/", "source_name": "TradingView", "published_at": "2026-06-09T15:39:59", "published_display": "09 Jun 2026 15:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies, Inc. Statistics \u2013 NASDAQ:PTN", "summary": "This page provides financial statistics for Palatin Technologies, Inc. (NASDAQ: PTN), including key financial stats, valuation ratios, profitability ratios, liquidity ratios, solvency ratios, and per-share metrics. Users can view annual and quarterly data from 2006 to 2025, altho", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/", "source_name": "TradingView", "published_at": "2026-06-08T22:39:59", "published_display": "08 Jun 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Revenue per share of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "The article focuses on the revenue per share information for Palatin Technologies, Inc. (NASDAQ: PTN), as presented on TradingView. It indicates that the market was closed at the time of viewing. The content primarily highlights the financial data and corporate information availa", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/revenue-per-share/", "source_name": "TradingView", "published_at": "2026-06-08T22:39:35", "published_display": "08 Jun 2026 22:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quick ratio of Palatin Technologies, Inc. \u2013 NASDAQ:PTN", "summary": "This article is a financial data page from TradingView for Palatin Technologies, Inc. (NASDAQ: PTN), focusing on its quick ratio. It provides a placeholder for the quick ratio value, change, and change percentage, and lists various services and disclaimers related to the market d", "url": "https://www.tradingview.com/symbols/NASDAQ-PTN/financials-statistics-and-ratios/quick-ratio/", "source_name": "TradingView", "published_at": "2026-06-08T12:10:36", "published_display": "08 Jun 2026 12:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies (PTN) Hovers Near Support as Biotech Sentiment Remains Cautious - Triple MA Cross", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPdWlWb28zbmtydDlCMV8yWE01VjNPa0dxTG5VZ2lNX0xSR0U3UXJfbE43bmJCcFl1YW1xZ3Nmd2FoYnZXdV81a1BOZE93VFJWWnlfYW5xZ1BMVWY3a0x2d3ZsT2FkbDlJb3diMUthandLbDl6MjNFbEc0SDI0MFF4b2NGbUNOcmR5T0I4YktfVllEZVNIcTV3TlpSVHUtSWJOeFJsSlQxTUFZQy1RSmM4NTE3eVVHUzQwT093MQ?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-08T07:00:00+00:00", "published_display": "08 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PTN Stock Price and Chart \u2014 NASDAQ:PTN", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE1uYkNzQVBUZDZOdjNnbXpQUW51bUtaLTg5cFExT2czS2xKZkxkVm5EcWkzR1BFOGlrbFlBb3NjVFJWbU54MTdWX2hWT3dsZ01nRGVXSlN3aHpvNXc?oc=5", "source_name": "TradingView", "published_at": "2026-05-29T09:18:43+00:00", "published_display": "29 May 2026 09:18", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies to Transfer Listing to Nasdaq", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/palatin-technologies-transfer-listing-nasdaq-213555362.html", "source_name": "MT Newswires", "published_at": "2026-05-18T21:35:55+00:00", "published_display": "18 May 2026 21:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin to Begin Trading on Nasdaq Stock Exchange", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOcV9xazhvWlI5ekxrNFBrSVZrN3lPOWRSLUlLY3ZVZjNFTU5kR3pOZ0tiQVp2YlZ2RUFKVml5Q2hMYzAzRUNHdjV0QkU5Xy1LWmJNWEExZDVQSklhME1zeDVmbDF3enQ0ZGxCV0FhX0VPWXRFV1BBUHAzM1ZGV29IQXBQajZJa21KWDZwZURmekk3QTJob0ljNTAwRDE4eEVZUC1KaW1tSy0?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Announced Transfer or Voluntary Withdrawal of Listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxONjlnN0tlM1NONVdCS0N1V00wVW5vbnpIWlY0YWp5Tk1NR3ZXVWtuMEluSUxMODkxVF9OelpUNHktTFhIX3l6T29TZ1dRMjZvbnZLZ1o1c0N2Q2E3ZklsTTVuRlh0VkkxYUZyeUNVdGZUc3daS0VBM1lIcEJfMVU2MlFiY2ZUSmJpTG55T2NVa080WHRjRkdyOFNFcUhnUmlva1NLcWozVVJsMEJJUXNCQUplTEJ6T0lGYXBSTlk4RTQ4OVRGbVRpZElLYVJKQm91YWc?oc=5", "source_name": "TradingView", "published_at": "2026-05-18T07:00:00+00:00", "published_display": "18 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies stock (US69608A1088): Q3 revenue jumps to $3.9M, loss narrows", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNaG1YbXQ2d1pyVFdCallxT2RlVzNDZ3E4bTJJZVl2T19EN3hwLUJmWFJPc0F3VTFXTVoyTlJkVDI1ZUlBOUhZZ2Yzb2hrN19KUGhMd2ZqdXgweWZfQ19yRzBvRi1FdTlLOFBhUEx4ZklHLUZGS2lLV0VHSVI5Znd0S1ItTVEtY003TkZQemtzTmhJa1NVX2ZlRnNkZnBNdW9IX2tVSnhFYmdVVzVYazJiWjJmX2JsUVJnZnRKNWE1TkxhQXFRWEww?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies Inc (PTN) Q3 2026 Earnings Call Highlights: Strategic Advances Amidst ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/palatin-technologies-inc-ptn-q3-230342249.html", "source_name": "GuruFocus.com", "published_at": "2026-05-13T23:03:42+00:00", "published_display": "13 May 2026 23:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Transcript: Palatin Techs Q3 2026 Earnings Conference Call", "summary": "", "url": "https://finance.yahoo.com/news/transcript-palatin-techs-q3-2026-153125171.html", "source_name": "Benzinga", "published_at": "2026-05-13T15:31:25+00:00", "published_display": "13 May 2026 15:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3AFBVV95cUxQSXBoS2dWSG1FalFVeHY2QWViamRvSmhlTVJFVDhDVWxrMHpUQ2o1OUN0LUVXb0RrR2ZMTUNhM2J5bTRDVWlSVENuMnlRbTVQNHhjOGZmN0RYUFZSY3EyMmtuRTVkcVFXY1FmbUd0OWhwcDJCTmZmV2FCUWlIdnd2TFFiV2lfTXVwTENCRVk4bEM1ZzdldXgzMjY4cnlXNWtySHJzeE1KYkhYam5wcWs1T1N5M0JBLXEwYXVXXzdsVV9Lcmg2UnJIUkl0R3AtNEJUUUt1RDg2Y01vNHJW?oc=5", "source_name": "PR Newswire", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Technologies (PTNT) Stock Price, News & Analysis $PTNT", "summary": "", "url": "https://news.google.com/rss/articles/CBMiW0FVX3lxTE5LNEFnbkNBVVZDOWsxVVpFaTBjOGZFMk9Jcjd3TV8tVDZfajYxMWh2Y1AwbFBrUWU0SE14ZUdPNzdKZmtkdTdTYU1Fa3dPQTJmd3dkSklWRkhXWnc?oc=5", "source_name": "MarketBeat", "published_at": "2026-03-16T19:04:03+00:00", "published_display": "16 Mar 2026 19:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNbk9ldkFQQlNMbXlUWGJNLVMwMDFLZ094Q2dydlpMb21pQmlnNXFtRW84bDhVeVJQVUdUbGszV3h3MkYwVXFLRi1icmFWTEtwaERVb1k1a19XbWFlR2RyQXRuNHpzSEZmVy1hcFZPQ1JhcllrVzBjVlgyV3lOalVHUUt2bzFQa1hvMGJTMjRsd081SzlSYkMzMTFLZDg5bFIwSU5CdmgzNHdVYmpmVEdURFotWE9taW5QWmI0bUtCRVRJejI2b0V1RGtJVUUxNzhqQjdHMy1La0ZWSXZYVXh5LTBHcHhmdw?oc=5", "source_name": "PR Newswire", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Molina Healthcare Stock Craters. Why Its Earnings Outlook Is So Bleak.", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPX1JJd3MzSGZ4Tl9ZWUduMTAtSUNrdVJDZFE2YnVGZzhvTUt6OXZNcHFPSG1LaWJ5a3NnQV9VeEZtYlNMVVlvaXZOanJreFVOcTd0U0phaUdhQUxjbFFwazc5S0ZYY1hWN25WalhXUGVQZEh5UnB3UDVWSzRoS3VsWnk5ek11X0k?oc=5", "source_name": "Barron's", "published_at": "2026-02-06T08:00:00+00:00", "published_display": "06 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 95, "total_relevant": 70, "sentiment_summary": {"positive": 11, "negative": 5, "neutral": 54, "score": 52, "total": 70, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 20.7, "count": 37}, {"event": "earnings", "label": "Earnings", "weight": 14.1, "count": 27}, {"event": "liquidity", "label": "Balance sheet", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 11, "negative_events": 5}, "market_context": {"has_market_context": true, "latest_close": 9.09, "latest_week": "2026-07-17", "one_week_move": -9.1, "four_week_move": -22.4, "twelve_week_move": -59.1, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.276229, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": -47.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 44.1288, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-9.1% over one week, -22.4% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 22}, {"label": "Market source", "count": 9}, {"label": "TradingKey", "count": 7}, {"label": "PR Newswire", "count": 3}, {"label": "Ad-hoc-news.de", "count": 2}, {"label": "Stock Titan", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Barron's", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 62}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 37}, {"label": "Earnings", "count": 27}, {"label": "Balance sheet", "count": 4}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "62", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-9.1% over one week, -22.4% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Palatin stock trades quietly as revenue stabilizes after FY 2025 loss"}], "updated_at": "2026-07-23T08:21:49.252769+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}